tradingkey.logo

Know Labs Inc

KNW
View Detailed Chart

0.457USD

+0.026+6.26%
Close 04/23, 16:00ETQuotes delayed by 15 min
50.79MMarket Cap
LossP/E TTM

Know Labs Inc

0.457

+0.026+6.26%
Intraday
1m
30m
1h
D
W
M
D

Today

+6.26%

5 Days

+6.26%

1 Month

-62.24%

6 Months

0.00%

Year to Date

0.00%

1 Year

0.00%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(2)
Buy(2)
Indicators
Sell(3)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.341
Sell
RSI(14)
19.374
Oversold
STOCH(KDJ)(9,3,3)
23.766
Neutral
ATR(14)
0.138
High Vlolatility
CCI(14)
-52.185
Neutral
Williams %R
70.950
Sell
TRIX(12,20)
-4.707
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
0.426
Buy
MA10
0.461
Sell
MA20
0.562
Sell
MA50
1.066
Sell
MA100
1.066
Sell
MA200
1.007
Sell

News

More news coming soon, stay tuned...

Company

Know Labs, Inc. is a developer of non-invasive diagnostics technology. The Company’s platform technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. The technology is designed to be able to integrate into a variety of wearable, mobile or bench-top form factors. Its patent-pending technology makes it possible to identify and monitor analytes that could only previously be performed by invasive and/or expensive and time-consuming lab-based tests. The Company’s expected application of the technology is focused on a product marketed as a non-invasive glucose monitor. The device is designed to provide the user with accessible and affordable real-time information on blood glucose levels. Its sensor technology embodies two key components: hardware and software. The hardware component includes a sensor which both sends and receives a radio frequency signal. The Company’s wholly owned subsidiary is Particle, Inc.
Company codeKNW
CompanyKnow Labs Inc
CEOMr. Ronald Peter Erickson, J.D.
Websitehttps://www.knowlabs.co/